Comparative analysis of ferumoxytol and gadoteridol enhancement using T1- and T2-weighted MRI in neuroimaging.

@article{Hamilton2011ComparativeAO,
  title={Comparative analysis of ferumoxytol and gadoteridol enhancement using T1- and T2-weighted MRI in neuroimaging.},
  author={Bronwyn E. Hamilton and Gary M. Nesbit and Edit D{\'o}sa and Seymur Gahramanov and Bill Rooney and Eric G Nesbit and Joshua Raines and Edward A Neuwelt},
  journal={AJR. American journal of roentgenology},
  year={2011},
  volume={197 4},
  pages={981-8}
}
OBJECTIVE Ferumoxytol, an ultrasmall superparamagnetic iron oxide particle, has been suggested as a potential alternative MRI contrast agent in patients with renal failure. We compared ferumoxytol to gadoteridol enhancement on T1- and T2-weighted MRI in CNS disorders to explore its diagnostic utility. SUBJECTS AND METHODS Data were collected from three protocols in 70 adults who underwent alternate-day gadoteridol- and ferumoxytol-enhanced MRI using identical parameters. Two neuroradiologists… CONTINUE READING
Recent Discussions
This paper has been referenced on Twitter 1 time over the past 90 days. VIEW TWEETS
21 Citations
20 References
Similar Papers

Citations

Publications citing this paper.
Showing 1-10 of 21 extracted citations

References

Publications referenced by this paper.
Showing 1-10 of 20 references

U.S. Food and Drug Administration. Feraheme (ferumoxytol) injection: detailed view—safety labeling changes approved by FDA Center for Drug Evaluation and Research (CDER)

  • U.S. Food and Drug Administration Website. www…
  • 2010
1 Excerpt

Feraheme (ferumoxytol injection) prescribing information

  • AMAg Pharmaceuticals
  • AMAg Pharmaceuticals Website. www.amagpharma.com…
  • 2009
2 Excerpts

Similar Papers

Loading similar papers…